{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Qato DM"],"funding":["NCATS NIH HHS","UMB ICTR"],"pagination":["350"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8091773"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["21(1)"],"pubmed_abstract":["<h4>Background</h4>Little is known about benzodiazepine and opioid-benzodiazepine co-dispensing patterns among pregnant women. Understanding these patterns is necessary to mitigate high-risk medication use during pregnancy. Our objective in this analysis was to evaluate opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States.<h4>Methods</h4>This retrospective study used a 10% random sample of commercially insured enrollees from the IQVIA™ Adjudicated Health Plan Claims Data from 2007 to 2015. The study included women (12-55 years of age) with completed pregnancies who had continuous medical and prescription drug coverage from 3 months prior to the date of conception through 3 months post-delivery. We estimated the preva"],"journal":["BMC pregnancy and childbirth"],"pubmed_title":["Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007-2015."],"pmcid":["PMC8091773"],"funding_grant_id":["1UL1TR003098-01","UL1 TR003098"],"pubmed_authors":["Gandhi AB","Qato DM"],"additional_accession":[]},"is_claimable":false,"name":"Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007-2015.","description":"<h4>Background</h4>Little is known about benzodiazepine and opioid-benzodiazepine co-dispensing patterns among pregnant women. Understanding these patterns is necessary to mitigate high-risk medication use during pregnancy. Our objective in this analysis was to evaluate opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States.<h4>Methods</h4>This retrospective study used a 10% random sample of commercially insured enrollees from the IQVIA™ Adjudicated Health Plan Claims Data from 2007 to 2015. The study included women (12-55 years of age) with completed pregnancies who had continuous medical and prescription drug coverage from 3 months prior to the date of conception through 3 months post-delivery. We estimated the preva","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 May","modification":"2026-07-16T10:30:28.047Z","creation":"2025-04-07T00:06:26.268Z"},"accession":"S-EPMC8091773","cross_references":{"pubmed":["33941106"],"doi":["10.1186/s12884-021-03787-5"]}}